Skip to main content

Akovaz FDA Approval History

FDA Approved: Yes (First approved April 29, 2016)
Brand name: Akovaz
Generic name: ephedrine sulfate
Dosage form: Injection
Company: Flamel Technologies
Treatment for: Hypotension

Akovaz (ephedrine sulfate) is a pressor agent administered parenterally to address clinically important hypotension in surgical settings.

Development timeline for Akovaz

May  2, 2016Approval Flamel Technologies Receives FDA Approval of Akovaz (ephedrine sulfate) for Surgical Hypotension

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.